Herborium Group

HBRM · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0001

About HBRM

Herborium Group, Inc. engages in the research, development, licensing, and trade of botanical therapeutic products. The company is headquartered in Missouri City, Texas. The firm responds to both consumers and healthcare professionals demand for treatment and prevention of selected diseases and health concerns. Its flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The company is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. AcnEase Skin Management System is a set of complementary all natural skin products which enhance the results of AcnEase. Its products include Natural Multi-tasking Acne Mask, Firming Collagen Peptide Serum, Accelerated Botanical Brightening Serum, Firming Collagen Peptide Serum, RETINOL RX, Mineral Sun Defense SPF 30, Vitamin C Antioxidant Serum and Glycolic Smoothing Serum.

Employees
0
Headquarters
Missouri City, Texas
Listed
Jul 10, 1998
Sector
Consumer Staples
Industry
Personal Care Products

HBRM key statistics

Market cap
1.14M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
376.82K
Volume
8.94K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

Herborium Group (HBRM) at a glance

Herborium Group (HBRM) last traded at $0.0001, with a market cap of 1.14M and a price-to-earnings ratio of 0.00.

Volume so far is 8.94K shares, below the average of 376.82K shares a day.

Over the past year Herborium Group has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

Similar companies

Companies in the same industry as Herborium Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.